2026 ACC/AHA multisociety guideline on the management of dyslipidemia
The 2026 guideline from the American College of Cardiology and the American Heart Association, with other societies named in its title, on managing dyslipidemia: high blood cholesterol, high triglycerides and elevated lipoprotein(a). Its abstract says it replaces the 2018 guideline on blood cholesterol. Only the abstract could be read, so this page gives no thresholds, targets or recommendations.
Also called 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia
- Guideline
- In this atlas
Overview
Technical summary
Circulation 2026;153(17):e1154-e1276, doi 10.1161/CIR.0000000000001423, PMID 41824552. Electronic publication 2026-03-13. Issued by the joint ACC/AHA committee on clinical practice guidelines. The title names nine more societies by abbreviation; the abbreviations alone do not tie them to records in this atlas, so only the ACC and the AHA are linked as issuers. The abstract does not name the risk equation the guideline uses. PubMed lists two corrections (2026-06-23 and 2026-09-08); their text was not read.
About this guideline
- Edition
- 2026 guideline
- Published
- 2026-03-13
- Status
- Not checked for a newer edition
- Scope
- Evaluation, management and monitoring of individuals with high blood cholesterol, high triglycerides and elevated lipoprotein(a).
Source
- Document
- 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
- Publisher
- Circulation
- Edition note
- Published in Circulation 153(17):e1154-e1276 (issue date 2026-04-28; electronic publication 2026-03-13). PubMed abstract and bibliographic data only. The guideline text was not read. PubMed lists 2 corrections to the guideline; their text was not read. The publisher field is the journal title as PubMed gives it.
Recommendations
No recommendation in this atlas names this guideline yet.
Claims and evidence
Context Individuals with dyslipidemia (2026 ACC/AHA multisociety guideline)
- Recipient
- Recipient not specified
- Population
- Individuals with dyslipidemias, which the abstract lists as high blood cholesterol, high triglycerides and elevated lipoprotein(a). The abstract gives no age limits and no inclusion or exclusion criteria.
- Care setting
- Not stated in the abstract. The abstract says the guideline covers evaluation, management and monitoring.
- Geography
- Not stated in the abstract (issued by American societies; jurisdiction not verified)
- Life stage
- Not stated in the abstract
- Gestational age
- Not reported
- Postnatal age
- Not reported
- Follow-up
- Not applicable (guideline context)
Eligibility: 1 inclusion criterion; exclusion criteria not stated
- Included
- Individuals with high blood cholesterol, high triglycerides or elevated lipoprotein(a), as the abstract describes the focus
- Excluded
- None stated
The abstract of the 2026 ACC/AHA multisociety dyslipidemia guideline says it retires and replaces the 2018 guideline on managing blood cholesterol. It says the guideline addresses evaluation, management and monitoring of people with high blood cholesterol, high triglycerides and elevated lipoprotein(a).
Source problem. A cited source is corrected. Check the sources before relying on this claim.
Applies to Recipient not specified- Individuals with dyslipidemias, which the abstract lists as high blood cholesterol, high triglycerides and elevated lipoprotein(a). The abstract gives no age limits and no inclusion or exclusion criteria.
- Not stated in the abstract. The abstract says the guideline covers evaluation, management and monitoring.
- Not stated in the abstract (issued by American societies; jurisdiction not verified)
- Not stated in the abstract
- Gestational age Not reported
- Postnatal age Not reported
- Certainty method
- Not assessed
- Limitations
- Only the abstract and the bibliographic record were read, so no threshold, target, medicine or class of recommendation from the guideline is recorded. PubMed lists two corrections to the guideline (2026-06-23 and 2026-09-08); their text was not read, so it is not known whether they change anything the abstract says. This claim states the replacement. It does not link to a record of the 2018 guideline.
- Last checked
- 2026-10-15
- Next evidence check due
- Not scheduled
Sources and citations (3)
-
- Locator
- Abstract, AIM
- How it applies
- The guideline retires and replaces the 2018 blood cholesterol guideline.
- Retrieved
- Source effective date
- Not reported
- Source state
- Corrected
- Snapshot hash
afe254bbde1b02392eb1f21622a009069be7cda3eb26453721b5c3ecdb6498ff- Reuse basis
- PubMed record fetched through NCBI E-utilities on 2026-10-15. Only the hash of the bytes is kept; nothing is committed. Bibliographic metadata and short quotations from the PubMed abstract, under 25 words each. The full text was not redistributed and the societies' reuse terms were not reviewed. Public text is quote under the PubMed abstract rule: only short quotations from the PubMed abstract, with attribution.
-
- Locator
- Abstract, STRUCTURE, sentence 1
- How it applies
- What the guideline addresses.
- Retrieved
- Source effective date
- Not reported
- Source state
- Corrected
- Snapshot hash
afe254bbde1b02392eb1f21622a009069be7cda3eb26453721b5c3ecdb6498ff- Reuse basis
- PubMed record fetched through NCBI E-utilities on 2026-10-15. Only the hash of the bytes is kept; nothing is committed. Bibliographic metadata and short quotations from the PubMed abstract, under 25 words each. The full text was not redistributed and the societies' reuse terms were not reviewed. Public text is quote under the PubMed abstract rule: only short quotations from the PubMed abstract, with attribution.
-
- Locator
- CommentsCorrectionsList, two ErratumIn entries
- How it applies
- Shows that corrections exist. What they change is unknown.
- Retrieved
- Source effective date
- Not reported
- Source state
- Corrected
- Snapshot hash
afe254bbde1b02392eb1f21622a009069be7cda3eb26453721b5c3ecdb6498ff- Reuse basis
- PubMed record fetched through NCBI E-utilities on 2026-10-15. Only the hash of the bytes is kept; nothing is committed. Bibliographic metadata and short quotations from the PubMed abstract, under 25 words each. The full text was not redistributed and the societies' reuse terms were not reviewed. Public text is quote under the PubMed abstract rule: only short quotations from the PubMed abstract, with attribution.
Record details
- Record id
cardio:guideline-acc-aha-2026-dyslipidemia- Content hash
ea5fdbd01fe6c7ab0ac2a46d43a4ef33d5bea8ef7ca85dfb7b7c845ce0768068